ActoGeniX to study mucositis treatment

DrBicuspid.com staff writers
Jun 22, 2009

ActoGeniX has gained U.S. FDA clearance to conduct a phase IB clinical trial of a new treatment for oral mucositis in cancer patients, the company announced.

There is currently no effective cure for the severely painful and debilitating inflammation and ulceration of the mucous membranes lining the mouth that makes eating, drinking, and speaking difficult or impossible.

Oral mucositis can affect up to 100% of cancer patients undergoing high-dose chemotherapy.

The FDA approval permits ActoGeniX to initiate a phase IB clinical trial in six major U.S. oncology centers. The treatment, known as AGO13, could become the first approved therapy for oral mucositis in patients undergoing treatment of solid tumors or head/neck cancers, according to ActoGeniX.

Copyright © 2009 DrBicuspid.com

Latest in Oral Cancer
Estela Vargas, CRDH.
Podcast: Estela Vargas dives deeper into dental practices getting paid for oral cancer screenings
May 9, 2024
Dentist Exam Woman
Poll: Too many not getting oral cancer screening
May 6, 2024
Michael Ventriello
5 ways dental-medical collaboration can improve oral cancer statistics
April 30, 2024
Dentist Counsel Patient
What dental teams can do to help prevent oral cancer
April 29, 2024
Related Stories
Reuterslogo
Oral Cancer
Palifermin decreases severe oral mucositis after radiotherapy
2011 04 01 14 54 58 95 2011 04 01 Nasa Light
Oral Cancer
NASA technology helps patients with oral mucositis
2008 10 09 10 19 45 634 000004323734
Oral Cancer
Managing the oral side effects of cancer treatment
2009 05 27 13 52 13 808 Girl Pain 70
Oral Cancer
Dentists may need to treat pediatric reflux disease
More in Oral Cancer
Podcast: Estela Vargas dives deeper into dental practices getting paid for oral cancer screenings
By Kevin Henry
In the latest episode of "The DrBicuspid.com Podcast," Estela Vargas, CRDH, follows up on a recent article delving into the importance of oral cancer screenings and how dental practices can get paid for them.
May 9, 2024
Estela Vargas, CRDH.
Poll: Too many not getting oral cancer screening
By Karie Neeley Anderson
Many people aren’t getting screened for oral cancer, know its link to HPV, and more, according to a poll.
May 6, 2024
Dentist Exam Woman
5 ways dental-medical collaboration can improve oral cancer statistics
By Michael Ventriello
By implementing five collaborative strategies, dentists and physicians can shift the oral cancer paradigm to significantly reduce oral cancer mortality rates and improve overall patient outcomes, writes Michael Ventriello.
April 30, 2024
Michael Ventriello
What dental teams can do to help prevent oral cancer
By Ava Barros
Educating patients about risk-reduction strategies, like promoting HPV vaccination, is crucial for the early detection and prevention of oral squamous cell carcinomas. The report was published in the Journal of Dental Hygiene.
April 29, 2024
Dentist Counsel Patient
What every dental practice must know about getting paid for oral cancer screenings
By Estela Vargas
There is no question that oral cancer screening is important for every practice, but what about the insurance side of the equation? Estela Vargas, CRDH, has some advice that can help on that front.
April 23, 2024
Estela Vargas, CRDH.
Cellerant CEO series: Vigilant Biosciences and advances in the battle against oral cancer
By Kevin Henry
As Oral Cancer Awareness Month continues, we take a look at a company that is using biomarkers as a way to catch oral cancer earlier and give patients a better chance of survival.
April 18, 2024
Bill Brodie
Nanoparticles to be developed to treat oral cancer
By Ava Barros
A lipid nanoparticles platform may treat oral squamous cell carcinoma by changing the genetic material of lymph nodes, according to research presented at the International Association for Dental, Oral, and Craniofacial Research.
April 1, 2024
Researcher
New test may be better way to detect oral cancer
By Ava Barros
A new test may detect a germ-fighting protein associated with oral cancer, track precancerous lesions, and determine when a biopsy is necessary. The study was recently published in Cell Reports Medicine.
March 26, 2024
Dr. Aaron Weinberg, PhD. Image courtesy of Case Western University.
Oral cancer detection with a stroke of a brush?
By Ava Barros
Researchers at the University of Illinois at Chicago College of Dentistry have created a diagnostic test kit that detects oral cancer early with a brush biopsy that can be done in a dental office, according to an article published by the university.
January 30, 2024
Cancer Cell
It’s not cheesy. An antimicrobial may treat oral cancer.
By Ava Barros
Researchers are conducting a clinical trial to determine whether an antimicrobial food additive found in cheese may be used to treat oral cell carcinoma, according to the University of California, Los Angeles School of Dentistry.
January 29, 2024
Bacteria Microscope
This numbing agent may kill HNC cells
By Ava Barros
The common dental numbing agent lidocaine triggers specific bitter taste receptors in the mouth that may ultimately lead to the death of head and neck cancer cells, according to a preclinical study recently published in Cell Reports.
December 5, 2023
Anesthetic Needle Vials
Young users of e-cigarettes more likely to report chronic stress
By Amerigo Allegretto
Young people who vape are more than twice as likely to report experiencing chronic stress.
October 3, 2023
Vaping Teenager
Page 1 of 116
Next Page